Loading...
•
Jun 30, 2025
Inotiv Q3 2025 Earnings Report
Estimated Revenue:$127M
+8.6% YoY
Estimated EPS:-$0.15
70.9% YoY
Key Takeaways
Inotiv delivered a strong third quarter in fiscal 2025, with revenue increasing by 23.5% year-over-year to $130.7 million, primarily due to growth in NHP-related products and services within the RMS segment and increased toxicology and biotherapeutic services in the DSA segment. The company also significantly reduced its operating loss from $20.8 million in Q3 FY 2024 to $5.7 million in Q3 FY 2025, largely due to improved RMS operating income and the absence of a prior year charge related to a DOJ agreement.
Third quarter fiscal 2025 revenue increased by 23.5% to $130.7 million compared to $105.8 million in the prior year.
Operating loss significantly decreased to $5.7 million in Q3 FY 2025 from $20.8 million in Q3 FY 2024, primarily due to a turnaround in RMS operating income.
RMS revenue saw a substantial increase of $21.0 million, driven by NHP-related product and service revenue.
DSA net awards for Q3 FY 2025 increased by 25% year-over-year, indicating strong future growth potential.
Forward Guidance
The report does not provide explicit forward-looking financial guidance for specific metrics like revenue or EPS for future quarters or the full fiscal year. However, management commentary suggests continued focus on financial goals and operational improvements.
Positive Outlook
- Continued progress towards financial goals outlined during the investor day in May.
- Revenue and margins improved over the second quarter.
- Year-over-year quarterly revenue increase was in line with expectations.
- DSA net awards increased significantly, indicating strong future business.
- Strong growth in quoting and awards in Discovery, Medical Device, Biotherapeutics, and Genetic Toxicology businesses.
Challenges Ahead
- No specific negative forward guidance was provided in the report.
- The company's cash and cash equivalents decreased significantly from the prior fiscal year end.
- Cash used in operating activities increased substantially year-to-date.
Loading...
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...